Allscripts Announces Third Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- Fed’s Warsh says central bank won’t tolerate high inflation
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
- IBM misses Q2 targets as mainframe and software sales disappoint
- Verizon planning new round of layoffs this week - Barron’s
- Goldman Sachs Upgrades NIO (NIO) to Buy
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
Allscripts (MDRX) Tops Q3 EPS by 9c
November 4, 2021 4:44 PM EDTAllscripts (NASDAQ: MDRX) reported Q3 EPS of $0.27, $0.09 better than the analyst estimate of $0.18. Revenue for the quarter came in at $369.2 million versus the consensus estimate of $375.39 million.
GUIDANCE:
Allscripts sees FY2021 revenue of $1.5 billion, versus the consensus of $1.5 billion.
For earnings history and earnings-related data on Allscripts (MDRX) click here.
... More